Factors affecting shared decision-making concerning menopausal hormone therapy

被引:1
|
作者
Koysombat, Kanyada [1 ,2 ]
Mukherjee, Annice [3 ]
Nyunt, Sandhi [1 ,2 ]
Pedder, Hugo [4 ]
Vinogradova, Yana [5 ]
Burgin, Jo [6 ]
Dave, Harshida [7 ]
Comninos, Alexander N. [1 ,2 ]
Talaulikar, Vikram [8 ]
Bailey, Julia V. [9 ]
Dhillo, Waljit S. [1 ,2 ]
Abbara, Ali [1 ,2 ]
机构
[1] Imperial Coll London, Fac Med, Dept Metab Digest & Reprod, Sect Endocrinol & Invest Med, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept Endocrinol, London, England
[3] Spire Manchester Hosp, Manchester, England
[4] Univ Bristol, Dept Populat Hlth Sci, Bristol, England
[5] Univ Nottingham, Sch Med, Div Primary Care, Nottingham, England
[6] Univ Bristol Sch Med, Ctr Acad Primary Care, Bristol, England
[7] Woman Representat Lived Experience Menopause, London, England
[8] Univ Coll Hosp, Reprod Med Unit, London, England
[9] UCL, Royal Free Hosp, Dept Primary Care & Populat Hlth, eHlth Unit, London, England
基金
美国国家卫生研究院;
关键词
hormone replacement therapy; menopausal hormone therapy; menopause; shared decision-making; REPLACEMENT THERAPY; SUPPORT FRAMEWORK; PHYSICIAN GENDER; BREAST-CANCER; HEALTH; WOMEN; RISK; COMMUNICATION; PROMOTION; CARE;
D O I
10.1111/nyas.15185
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Menopausal hormone therapy (MHT) is an effective treatment for menopause-related symptoms. Menopause management guidelines recommend a personalized approach to menopause care, including MHT use. Decision-making around menopause care is a complex, iterative process influenced by multiple factors framed by perspectives from both women and healthcare providers (HCPs). This narrative review aims to summarize evidence around factors affecting decision-making regarding menopause-related care. For HCPs, the provision of individualized risk estimates is challenging in practice given the number of potential benefits and risks to consider, and the complexity of the data available, especially within time-limited consultations. Women seeking menopause care have the difficult task of making sense of the benefit versus risk profiles to make choices in line with their decisional needs influenced by sociocultural/economic, educational, demographic, and personal characteristics. The press, social media, and influential celebrities also impact the perception of menopause and decision-making around it. Understanding these factors can lead to improved participation in shared decision-making, satisfaction with the decision and decision-making process, adherence to treatment, reduced decisional regret, efficient use of resources, and ultimately long-term satisfaction with care. Menopausal hormone therapy (MHT) effectively treats menopause-related symptoms. A personalized approach is recommended by menopause management guidelines. Decision-making in menopause care is complex. Healthcare providers face challenges in providing individualized risk estimates due to data complexity and time constraints. Women must balance benefits and risks, and influences from socio-cultural, economic, education, and personal factors. Media and celebrities also impact perceptions. Understanding these factors enhances shared decision-making, treatment adherence, and satisfaction. image
引用
收藏
页码:34 / 44
页数:11
相关论文
共 50 条
  • [1] Menopausal hormone therapy: What should be kept in mind for a personalized choice in a shared decision-making
    Franceschini, Gianluca
    Lello, Stefano
    Di Leone, Alba
    Orlandi, Armando
    Masetti, Riccardo
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 246 : 191 - 192
  • [2] Hormone replacement therapy (HRT) as preventive medicine for post-menopausal women (PMW): A shared decision-making model
    Sacks, HS
    Rose, DN
    Clark, JM
    Lau, J
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (02) : 230A - 230A
  • [3] Computerized hybrid decision-making system for hormone replacement therapy in menopausal women
    Bacak, H. Ozge
    Leblebicioglu, Kemal
    Tanacan, Atakan
    Beksac, Mehmet Sinan
    TECHNOLOGY AND HEALTH CARE, 2019, 27 (01) : 49 - 59
  • [4] Nonclinical Factors Affecting Shared Decision Making
    Smith, Grace L.
    Volk, Robert J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (04): : 391 - 391
  • [5] Shared decision-making on the use of hormone therapy: a nationwide survey in the Republic of Korea
    An, Ah Reum
    Shin, Dong Wook
    Chun, So Hyun
    Lee, Hyun-Ki
    Ko, Young-Jin
    Lee, Hyejin
    Son, Ki Young
    Choi, Ho-Chun
    Cho, Belong
    Lee, Jong-koo
    Kim, Jung Gu
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (07): : 726 - 731
  • [6] Shared Decision-Making in Growth Hormone Therapy-Implications for Patient Care
    Acerini, Carlo L.
    Segal, David
    Criseno, Sherwin
    Takasawa, Kei
    Nedjatian, Navid
    Rohrich, Sebastian
    Maghnie, Mohamad
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [7] Shared Decision-Making Is Not Patient Decision-Making
    Birnbrich, Alysa
    McCulloch, Patrick C.
    Kraeutler, Matthew J.
    SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH, 2023, 15 (04): : 615 - 616
  • [8] FACTORS AFFECTING CONFERENCE PARTICIPATION DECISION-MAKING
    Pavlukovic, Vanja
    Cimbaljevic, Marija
    JOURNAL OF THE GEOGRAPHICAL INSTITUTE JOVAN CVIJIC SASA, 2020, 70 (01): : 31 - 43
  • [9] Shared decision-making
    Dirksen-Fischer, M
    GESUNDHEITSWESEN, 2004, 66 (05) : 318 - 318
  • [10] Shared decision-making
    Steven, K
    BRITISH JOURNAL OF GENERAL PRACTICE, 2001, 51 (462): : 61 - 62